Champions Oncology, Inc.
General ticker "CSBR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $105.5M (TTM average)
Champions Oncology, Inc. does not follow the US Stock Market performance with the rate: -11.6%.
Estimated limits based on current volatility of 2.0%: low 7.08$, high 7.36$
Factors to consider:
- Total employees count: 210 (-8.7%) as of 2024
- Top business risk factors: Economic downturns and volatility, Inability to raise capital, Pandemic risks, Political instability in israel, Market competition
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-04-30 to 2027-04-30
- 2025-04-30 to 2026-04-30 estimated range: [5.14$, 10.26$]
- 2026-04-30 to 2027-04-30 estimated range: [4.52$, 9.24$]
Financial Metrics affecting the CSBR estimates:
- Positive: with PPE of 22.5 at the end of fiscal year the price was low
- Positive: 7.54 < Operating profit margin, % of 8.51
- Positive: 6.63 < Operating cash flow per share per price, % of 7.08
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -1.77 <= -0.76
- Positive: Investing cash flow per share per price, % of -0.37 > -0.62
Short-term CSBR quotes
Long-term CSBR plot with estimates
Financial data
| YTD | 2023-04-30 | 2024-04-30 | 2025-04-30 |
|---|---|---|---|
| Operating Revenue | $53.87MM | $49.72MM | $56.94MM |
| Operating Expenses | $59.13MM | $57.08MM | $52.10MM |
| Operating Income | $-5.26MM | $-7.36MM | $4.85MM |
| Non-Operating Income | $-0.01MM | $0.05MM | $-0.22MM |
| Interest Expense | $0.00MM | $0.00MM | $0.03MM |
| R&D Expense | $11.54MM | $9.54MM | $6.83MM |
| Income(Loss) | $-5.27MM | $-7.31MM | $4.63MM |
| Taxes | $0.07MM | $-0.03MM | $-0.07MM |
| Profit(Loss)* | $-5.33MM | $-7.28MM | $4.70MM |
| Stockholders Equity | $4.64MM | $-1.90MM | $3.77MM |
| Assets | $34.31MM | $26.13MM | $32.34MM |
| Operating Cash Flow | $3.97MM | $-6.14MM | $7.39MM |
| Capital expenditure | $2.87MM | $0.84MM | $0.39MM |
| Investing Cash Flow | $-2.87MM | $-0.84MM | $-0.39MM |
| Financing Cash Flow | $0.01MM | $-0.53MM | $0.17MM |
| Earnings Per Share** | $-0.39 | $-0.54 | $0.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.